Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-23-006330

Principal Accounting Officer sold 3,529 shares at an average $8.57 ($30,246)

  • Principal Accounting Officer acquired 43,735 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

PISKEL KYLE · Principal Accounting Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-06 Grant or award : show line 1 in the form +43,735 91,093 D
2023-03-06 Sale : show line 2 in the form −3,300 $8.57 $28,281 87,793 D
2023-03-06 Sale : show line 3 in the form −229 $8.58 $1,965 87,564 D
Open-market sales · 3,529 sh · avg $8.57 · $30,246
Loading xslF345X03/form4.xml…